Journal
CHEMICAL SOCIETY REVIEWS
Volume 45, Issue 9, Pages 2440-2457Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5cs00699f
Keywords
-
Categories
Funding
- European Commission
- MINECO [MAT2013-48169-R]
- BMBF-MRCyte/NanoBEL
- Zeiss-ChemBioMed
- Stiftung Rheinland-Pfalz (NanoScreen)
- Peter und Traudl Engelhorn foundation
- BIOMATICS
- DFG SPP1313
- CNRS (Centre National de la Recherche Scientifique)
- ANR (Agence Nationale de la Recherche)
- CGI (Commissariat a l'Investissement d'Avenir) through the LabEx SEAM (Science and Engineering for Advanced Materials and devices) [ANR 11 LABX 086, ANR 11 IDEX 05 02]
- Alexander von Humboldt Foundation
- Lars Hierta Memorial Foundation
Ask authors/readers for more resources
What happens to inorganic nanoparticles (NPs), such as plasmonic gold or silver, superparamagnetic iron oxide, or fluorescent quantum dot NPs after they have been administrated to a living being? This review discusses the integrity, biodistribution, and fate of NPs after in vivo administration. The hybrid nature of the NPs is described, conceptually divided into the inorganic core, the engineered surface coating comprising of the ligand shell and optionally also bio-conjugates, and the corona of adsorbed biological molecules. Empirical evidence shows that all of these three compounds may degrade individually in vivo and can drastically modify the life cycle and biodistribution of the whole heterostructure. Thus, the NPs may be decomposed into different parts, whose biodistribution and fate would need to be analyzed individually. Multiple labeling and quantification strategies for such a purpose will be discussed. All reviewed data indicate that NPs in vivo should no longer be considered as homogeneous entities, but should be seen as inorganic/organic/biological nanohybrids with complex and intricately linked distribution and degradation pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available